United Therapeutics Corporation Finite-Lived Intangible Asset, Expected Amortization, Year One
United Therapeutics Corporation (UTHR) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $1.00 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-25
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $1.00M 10-K · filed 2026-02-25 |
| 2024-12-31 | $1.00M 10-K · filed 2025-02-26 |
| 2023-12-31 | $1.00M 10-K · filed 2024-02-21 |
| 2022-12-31 | $1.00M 10-K · filed 2023-02-22 |
| 2021-12-31 | $1.00M 10-K · filed 2022-02-24 |
| 2015-12-31 | $621.00K 10-K · filed 2016-02-25 |
| 2014-12-31 | $1.08M 10-K · filed 2015-02-24 |
| 2013-12-31 | $1.39M 10-K · filed 2014-02-25 |
| 2013-09-30 | $1.36M 10-Q · filed 2013-10-29 |
| 2013-06-30 | $1.31M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $1.50M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $1.96M 10-K · filed 2013-02-26 |
| 2012-09-30 | $1.92M 10-Q · filed 2012-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |